Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of LF111 (drospirenone 4.0 mg 24/4) with scheduled 24-hour delays in pill intake
2013-001513-33Phase 2Completed
- Sponsor
- Laboratorios Leon Farma
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of drospirenone in None, sponsored by Laboratorios Leon Farma. Primary endpoint: Ovulation incidence. Started May 2013; status: completed.
02
Drugs
drospirenone
Beyond the preview
Go deeper on 2013-001513-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001513-33.